Abstract
Introduction: Head and neck (H&N) sarcomas are histologically diverse and constitute only 1 % of all H&N malignancies. Standard management involves either chemoradiation or surgical excision with adjuvant therapy, but despite therapeutic advances, prognosis remains poor. Methods: Retrospective review of all patients with H&N sarcoma treated at the Edinburgh Cancer Research Centre between 1999-2019 (n=55) was performed. Patients were divided into paediatric (
| Original language | English |
|---|---|
| Publication status | Published - 26 Feb 2020 |
| Event | British Sarcoma Group Conference 2020 - Glasgow, United Kingdom Duration: 26 Feb 2020 → 27 Feb 2020 |
Conference
| Conference | British Sarcoma Group Conference 2020 |
|---|---|
| Country/Territory | United Kingdom |
| City | Glasgow |
| Period | 26/02/20 → 27/02/20 |
Keywords
- head sarcoma
- neck sarcoma
- cancer management